The Effect of Perioperative Bevacizumab on Disease-Free and Overall Survival in Locally Advanced HER-2 Negative Breast Cancer: A Meta-Analysis

INTRODUCTION: Multiple trials demonstrated that adding Bevacizumab to the standard neoadjuvant chemotherapy in HER-2 negative breast cancer increases pathological complete response. We conducted this meta-analysis to evaluate that effect on survival. METHODS: We performed a systematic search for ran...

Descripción completa

Detalles Bibliográficos
Autores principales: Alnimer, Yanal, Hindi, Zakaria, Katato, Khalil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6077892/
https://www.ncbi.nlm.nih.gov/pubmed/30090017
http://dx.doi.org/10.1177/1178223418792250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6077892/
https://www.ncbi.nlm.nih.gov/pubmed/30090017
http://dx.doi.org/10.1177/1178223418792250

Ejemplares similares